HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
Huagongshe Open Program:[email protected]AI access: llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.7.8
  1. Home
  2. /Compound

Gallamine Triethiodide

HCID 6172
NotesReactions
Basic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
65-29-2
Standard SMILES
CC[N+](CC)(CC)CCOc1cccc(OCC[N+](CC)(CC)CC)c1OCC[N+](CC)(CC)CC.[I-].[I-].[I-]
InChIKey
REEUVFCVXKWOFE-UHFFFAOYSA-K
Molecular formula
C30H60I3N3O3
Average molar mass
891.5 g/mol
Monoisotopic mass
891.1769

Overview

A synthetic nondepolarizing blocking drug. The actions of gallamine triethiodide are similar to those of tubocurarine, but this agent blocks the cardiac vagus and may cause sinus tachycardia and, occasionally, hypertension and increased cardiac output. It should be used cautiously in patients at risk from increased heart rate but may be preferred for patients with bradycardia. (From AMA Drug Evaluations Annual, 1992, p198)

Names & identifiers

Preferred name
Gallamine Triethiodide
IUPAC
2-[2,3-bis[2-(triethylazaniumyl)ethoxy]phenoxy]ethyl-triethylazanium triiodide
English name
Gallamine triethiodide
Molecular formula
C30H60I3N3O3
Molecular weight
891.53

Names & synonyms

GALLAMINE TRIETHIODIDE65-29-2FlaxedilBenzcurine iodideRemyolanSyncurarineRelaxanSincurarineRetensinTricuranGallaminii iodidumGallamine-3ETI
Show more names
gallaminef2559rp3697gallaminflacedil
Gallamine triiodoethylateFourneau 2559Gallamine iodideGallamina triodoetilatoGallamini triethiodidumTriethiodure de gallamineGallamin triethiodideGallamone triethiodide

Database identifiers

CAS
65-29-2
PubChem CID
6172
DTXSID
DTXSID5023089
ChEMBL
CHEMBL1200993
UNII
Q3254X40X2
EC Number
200-605-1

Properties

Computed structural properties

Topological polar surface area
27.7 Ų
Hydrogen bond donors
0
Hydrogen bond acceptors
6
Rotatable bonds
21
Heavy atoms
39
Formal charge
0
Complexity
489

Experimental & physicochemical properties

OdorODORLESS
Color/Form · 2 items

WHITE AMORPHOUS POWDER

White crystals from acetone/water

Solubility · 3 items

Soluble

Freely sol in water, alcohol, dil acetone; sparingly sol in anhyd acetone, ether, benzene, chloroform

Very soluble in water and ethanol; slightly soluble in ethyl ether and acetone.

Human Drugs · 2 items

FDA approved drugs -> Active ingredient

FDA approved drugs -> Active ingredient

DecompositionWhen heated to decomposition it emits very toxic fumes of ammonia, nitroxides, and iodine.
Melting Point · 2 items

152-153

147.5 °C

Other Experimental PropertiesHYGROSCOPIC

Physicochemical properties

Melting point

Safety & regulation

Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.

GHS classification

GHS Classification · 4 items

Warning

H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]

P261, P264, P264+P265, P270, P271, P280, P301+P317, P302+P352, P304+P340, P305+P351+P338, P319, P321, P330, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 39 reports by companies from 2 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

Hazard information

Regulatory InformationEthanaminium, 2,2',2''-[1,2,3-benzenetriyltris(oxy)]tris[N,N,N-triethyl-, triiodide: Does not have an individual approval but may be used under an appropriate group standard
Other Safety InformationIMAP assessments - Ethanaminium, 2,2',2''-[1,2,3-benzenetriyltris(oxy)]tris[N,N,N-triethyl-, triiodide: Human health tier I assessment
FDA Requirements · 1 item

Manufacturers, packers, and distributors of drug and drug products for human use are responsible for complying with the labeling, certification, and usage requirements as prescribed by the Federal Food, Drug, and Cosmetic Act, as amended (secs 201-902, 52 Stat. 1040 et seq., as amended; 21 U.S.C. 321-392).

Hazard Classes and CategoriesAcute Tox. 4 (100%)

Safety & protection

Disposal Methods · 1 item

SRP: At the time of review, criteria for land treatment or burial (sanitary landfill) disposal practices are subject to significant revision. Prior to implementing land disposal of waste residue (including waste sludge), consult with environmental regulatory agencies for guidance on acceptable disposal practices.

Chemistry & industry

Pharmacology

Pharmacodynamics · 1 item

Gallamine Triethiodide is a nondepolarizing neuromuscular blocking drug (NDMRD) used as an adjunct to anesthesia to induce skeletal muscle relaxation. The actions of gallamine triethiodide are similar to those of tubocurarine, but this agent blocks the cardiac vagus and may cause sinus tachycardia and, occasionally, hypertension and increased cardiac output. Muscle groups differ in their sensitivity to these types of relaxants with ocular muscles (controlling eyelids) being most sensitive, followed by the muscles of the neck, jaw, limbs and then abdomen. The diaphragm is the least sensitive muscle to NDMRDs. Although the nondepolarizing neuromuscular blocking drugs do not have the same adverse effects as succinylcholine, their onset of action is slower. They also have a longer duration of action, making them more suitable for maintaining neuromuscular relaxation during major surgical procedures.

Mechanism of Action · 4 items

It competes with acetylcholine (ACh) molecules and binds to muscarinic acetylcholine receptors on the post-synaptic membrane of the motor endplate. It acts by combining with the cholinergic receptor sites in muscle and competitively blocking the transmitter action of acetylcholine. It blocks the action of ACh and prevents activation of the muscle contraction process. It can also act on nicotinic presynaptic acetylcholine receptors which inhibits the release of ACh.

GALLAMINE TRIETHIODIDE...PRODUCES SKELETAL MUSCLE RELAXATION BY COMBINING WITH RECEPTOR SITE AT NEUROMUSCULAR JUNCTION & BLOCKING ACTION OF NEUROTRANSMITTER ACETYLCHOLINE.

IN RAT PHRENIC NERVE-DIAPHRAGM GALLAMINE HAD NO SIGNIFICANT EFFECTS ON ELECTROGENIC PROPERTIES OF EXCITABLE MEMBRANES OF MOTOR NERVE TERMINALS & MUSCLE FIBERS; IT DEPRESSED RESPONSE OF POSTSYNAPTIC RECEPTORS TO ACTION OF ACETYLCHOLINE.

AT NEUROMUSCULAR JUNCTIONS IN MICE AND FROGS, FOLLOWING STEP CHANGES OF MEMBRANE POTENTIAL FROM -70 TO -130 MV, GALLAMINE (5 UMOL) IN THE PRESENCE OF ACETYLCHOLINE (3 UMOL) CAUSED AN INITIAL RAPID DECR IN CURRENT FOLLOWED BY OPENING OF CHANNELS AT A SLOWER RATE THAN WITH ACETYLCHOLINE ALONE. WHEN THE INTERNAL POTENTIAL WAS REDUCED TO -70 MV, THERE WAS A RAPID INCR IN CURRENT AT FIRST, FOLLOWED BY THE USUAL DECR WHICH WAS AGAIN SLOWER THAN NORMAL. THUS, GALLAMINE MAY PRODUCE A POTENTIAL-DEPENDENT BLOCK OF OPEN ION CHANNELS.

Biological Half-Life135 minutes /From table/

Related reactions

0 records
New reaction record

No reaction records under the current filter.

Compound notes

Loading…

On this pageBasic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
235 °C · 235 °C (dec.) (lit.)
Density
1.4288 · 1.4288 (estimate)
storage temp.
2 · 2-8°C
solubility
2 O: · H2O: 100 mg/mL
form
powder
color
2 CO · Crystals from Me2CO (aq)
Water Solubility
2 O: · H2O: 100mg/mLethanol: soluble
Merck
13 · 13,4364
InChIKey
REEUVFCVXKWOFE-UHFFFAOYSA-K
SMILES
C1(OCC[N+](CC)(CC)CC)=C(C=CC=C1OCC[N+](CC)(CC)CC)OCC[N+](CC)(CC)CC.[I-].[I-].[I-]
FDA UNII
3254 X40X2 · Q3254X40X2
ATC code
3 AC02 · M03AC02
UNSPSC Code
12352116 · 12352116
NACRES
77 · NA.77
Symbol(GHS)
7 · GHS07
Signal word
Warning
Hazard statements
302 · H302
Precautionary statements
301 · P301+P312+P330
PPE
95 · dust mask type N95 (US), Eyeshields, Gloves
Hazard Codes
Xn
Risk Statements
22 · 22-36/37/38
Safety Statements
26 · 26-36-45
WGK Germany
3 · 3
RTECS
1100000 · BS1100000
HS Code
29239000 · 29239000
Storage Class
11 · 11 - Combustible Solids
Hazard Classifications
4 Oral · Acute Tox. 4 Oral
Hazardous Substances Data
65 · 65-29-2(Hazardous Substances Data)
Toxicity
50 oral · LD50 oral in rabbit: 100mg/kg

Toxicology

Interactions · 5 items

IN ANESTHETIZED PT, IV ADMIN OF DIAZEPAM MAY INCR INTENSITY & PROLONG DURATION OF NEUROMUSCULAR BLOCKADE PRODUCED BY GALLAMINE TRIETHIODIDE. CLINICAL REPORTS...ARE CONFLICTING.../&/ THERE ARE INSUFFICIENT DATA TO EXPLAIN POSSIBLE MECHANISM FOR GALLAMINE TRIETHIODIDE-DIAZEPAM INTERACTION.

NEUROMUSCULAR BLOCKADE PRODUCED BY TUBOCURARINE WAS PROLONGED IN TWO THYROTOXIC PT RECEIVING HIGH DOSES (120 MG/DAY FOR 14 DAYS) OF PROPRANOLOL. ... ALTHOUGH THERE IS NO DOCUMENTATION, THE NONDEPOLARIZING MUSCLE RELAXANT GALLAMINE TRIETHIODIDE...ALSO SHOULD INTERACT WITH PROPRANOLOL.

NEOMYCIN &...RELATED ANTIBIOTICS PRODUCE NEUROMUSCULAR TRANSMISSION FAILURE WHICH MAY CAUSE PROLONGED RESP DEPRESSION OR APNEA IN SURGICAL PT TREATED CONCURRENTLY WITH TUBOCURARINE &...NEUROMUSCULAR DEPRESSANTS. ...ADDITIVE NEUROMUSCULAR DEPRESSION.../REPORTED TO OCCUR WITH GALLAMINE TRIETHIODIDE/.

QUINIDINE, ADMIN PARENTERALLY SHORTLY AFTER OR SIMULTANEOUSLY WITH TUBOCURARINE, MAY ENHANCE OR CAUSE RECURRENT NEUROMUSCULAR EFFECTS OF TUBOCURARINE, RESULTING IN PROLONGATION OR INTENSIFICATION OF RESP DEPRESSION & APNEA. ... GALLAMINE TRIETHIODIDE...HAS BEEN SHOWN TO INTERACT WITH QUINIDINE IN ANIMALS.

For more Interactions (Complete) data for GALLAMINE TRIETHIODIDE (25 total), please visit the HSDB record page.

Human Toxicity Excerpts · 3 items

POISONING ... IS ALMOST ALWAYS RESULT OF CLINICAL OVERDOSAGE ... DIRECTLY RELATED FACTORS MAY ... INCL ALTERATIONS IN BODY TEMP ... ELECTROLYTE IMBALANCE, PARTICULARLY OF POTASSIUM ... /NEUROMUSCULAR BLOCKING AGENTS/

THREE CASES OF SEVERE ANAPHYLAXIS TO GALLAMINE TRIETHIODIDE ARE DESCRIBED. ALL REPORTED CASES HAVE OCCURRED IN WOMEN, & ALL CONFIRMED CASES IN AUSTRALASIA. THERE IS EVIDENCE THAT WOMEN MAY BE EXPOSED TO SOME SUBSTANCE WHICH LEAVES THEM SENSITIVE TO GALLAMINE TRIETHIODIDE.

Accidental subarachnoid injection of gallamine in an adult is followed by muscle spasms of the lower limbs and anxiety; by 3 hr the arterial pressure and pulse rate increases followed by hyperthermia, profuse sweating, intense hyperesthesia, loss of consciousness, and pinpoint pupils. Within 24 hr the muscle spasms lessen.

Drug Induced Liver Injury · 5 items

Drug-Induced Liver Injury Severity and Toxicity (DILIst)

gallamine triethiodide

DILI Negative

Intravenous

DOI:10.1016/j.drudis.2019.09.022

Non-Human Toxicity Excerpts · 5 items

LD50 VALUES OF GALLAMINE TRIETHIODIDE AFTER IV, IP, & SC INJECTIONS WERE 3.0-3.3, 15.3-15.8, & 16.4-17.1 MG/KG IN MICE. VALUES AFTER ORAL ADMIN WERE GREATER THAN 1000 MG/KG. RESP DISORDER WAS MAJOR CAUSE OF DEATH.

LD50 VALUES OF GALLAMINE TRIETHIODIDE AFTER IV, IP, & SC INJECTIONS WERE 5.1-5.4, 23.2-26.7 & 28.5-34.3 MG/KG IN RATS. VALUES AFTER ORAL ADMIN WERE GREATER THAN 1000 MG/KG. IV LD50 IN RABBITS WAS 0.46 MG/KG. RESP DISORDER WAS MAJOR CAUSE OF DEATH IN THESE ANIMALS.

COMPARED TO CONTROL ANIMALS, ONSET OF ACTION OF GALLAMINE TRIETHIODIDE WAS SIGNIFICANTLY DELAYED IN HEMORRHAGIC (HYPOTENSIVE) DOGS. RECOVERY FROM GALLAMINE TRIETHIODIDE INDUCED PARALYSIS OCCURRED IN CONTROL DOGS, BUT NO SIGNS OF RECOVERY IN HEMORRHAGIC ANIMALS.

BLOOD & TISSUE SAMPLES WERE TAKEN FROM MALE RATS PREVIOUSLY TREATED IV WITH NEUROMUSCULAR BLOCKING AGENTS. GALLAMINE TRIETHIODIDE (40 MG/KG) WAS MODERATE HISTAMINE LIBERATOR. PANCURONIUM BROMIDE (2 MG/KG) RELEASED NO HISTAMINE. SOURCES OF INCR BLOOD HISTAMINE CONCN ARE TONGUE & SKIN WITH HIGH HISTAMINE CONTENT. NO RELEASE OF HISTAMINE FROM LUNG WAS OBSERVED.

For more Non-Human Toxicity Excerpts (Complete) data for GALLAMINE TRIETHIODIDE (7 total), please visit the HSDB record page.

Non-Human Toxicity Values · 5 items

LD50 Rat ip 23,200 ug/kg

LD50 Rat sc 28,500 ug/kg

LD50 Rat iv 5100 ug/kg

LD50 Rat intraduodenal 380 mg/kg

For more Non-Human Toxicity Values (Complete) data for GALLAMINE TRIETHIODIDE (13 total), please visit the HSDB record page.

Regulatory information

FDA Requirements · 1 item

Manufacturers, packers, and distributors of drug and drug products for human use are responsible for complying with the labeling, certification, and usage requirements as prescribed by the Federal Food, Drug, and Cosmetic Act, as amended (secs 201-902, 52 Stat. 1040 et seq., as amended; 21 U.S.C. 321-392).

Safety data

PPE
dust mask type N95 (US), Eyeshields, Gloves
wgk
3
rtecs
BS1100000
hs_code
29239000
Toxicity
LD50 oral in rabbit: 100mg/kg
risk_code
22-36/37/38
Signal word
Warning
Symbol(GHS)
GHS07
hazard_code
Xn
safety_code
26-36-45
Storage Class
11 - Combustible Solids
Hazard statements
H302
Hazard Classifications
Acute Tox. 4 Oral
Precautionary statements
P301+P312+P330
Hazardous Substances Data
65-29-2(Hazardous Substances Data)
Metabolism/Metabolites.../GALLAMINE/ IS UNMETABOLIZED. /GALLAMINE/
MeSH Pharmacological Classification · 2 items

Drugs that interrupt transmission at the skeletal neuromuscular junction without causing depolarization of the motor end plate. They prevent acetylcholine from triggering muscle contraction and are used as muscle relaxants during electroshock treatments, in convulsive states, and as anesthesia adjuvants.

Drugs that bind to nicotinic cholinergic receptors (RECEPTORS, NICOTINIC) and block the actions of acetylcholine or cholinergic agonists. Nicotinic antagonists block synaptic transmission at autonomic ganglia, the skeletal neuromuscular junction, and at central nervous system nicotinic synapses.

Absorption, Distribution and Excretion · 5 items

STUDIES HAVE DEMONSTRATED THAT GALLAMINE IS EXCRETED IN DOG URINE AT RATE FASTER THAN OTHER MUSCLE RELAXANTS. .../IT/ DID NOT CROSS BLOOD-CEREBROSPINAL FLUID BARRIER. OTHER STUDIES...HAVE DETECTED GALLAMINE IN CEREBROSPINAL FLUID IN CONCN APPROACHING THOSE IN PLASMA DURING 1ST HR AFTER IV INJECTION. /GALLAMINE/

GALLAMINE IS ELIMINATED MAINLY BY RENAL EXCRETION...

... GALLAMINE CROSSES PLACENTAL BARRIER ...

TRACE AMT OF GALLAMINE APPEARS IN FETUS 3 MIN AFTER ADMIN. /GALLAMINE, FROM TABLE/

For more Absorption, Distribution and Excretion (Complete) data for GALLAMINE TRIETHIODIDE (6 total), please visit the HSDB record page.

Uses & manufacturing

UsesMEDICATION
Methods of Manufacturing · 2 items

PYROGALLOL IS CONDENSED WITH 2-CHLOROTRIETHYLAMINE & RESULTING TRIAMINE [2,2''',2''''''-(V-PHENENYLTRIOXY)TRIS(TRIETHYLAMINE)] IS QUATERNIZED WITH ETHYL IODIDE IN BOILING ACETONE. CRUDE PRODUCT WHICH PPT IS PURIFIED BY REPEATED CRYSTALLIZATION FROM HOT ETHANOL.

Prepared by reaction of pyrogallol with diethylaminoethyl chloride and subsequent alkylation with ethyl iodide.

Formulations/PreparationsGALLAMINE TRIETHIODIDE, USP (FLAXEDIL), IS AVAIL AS STERILE SOLN CONTAINING 20 OR 100 MG/ML.
General Manufacturing InformationPharmaceutical incompatibilities: meperidine hydrochloride (solutions must not be mixed /with gallamine triethiodide/).
Applications · 4 items

UsesMuscle relaxant;M2 antagonist allosteric

UsesGallamine triethiodide has been used:as a relaxant for measuring spinal trigeminal nucleus recordings from single neurons.as an antagonist in neuroblastoma cells as M2 receptorto reduce eye movement during retinal surgery in rat

UsesGallamine Triethiodide is used as a neuromuscular blocking agent, paralyzing locally during anesthetization.

General DescriptionGallamine triethiodide,[v-phenenyl-tris(oxyethylene)]tris[triethylammonium] triiodide(Flaxedil), is a skeletal muscle relaxant that works byblocking neuromuscular transmission in a manner similar tothat of d-tubocurarine (i.e., a nondepolarizing blockingagent). It does have some differences, however. It has astrong vagolytic effect and a persistent decrease in neuromuscularfunction after successive doses that cannot be overcome by cholinesterase inhibitors. Gallamine triethiodidealso has muscarinic antagonistic properties and bindswith greater affinity to the M2 receptors than to the M1 receptor.This latter characteristic may cause its strongvagolytic action.

Upstream & downstream products

Upstream raw materials

PyrogallolIodoethaneSodium amide2,2',2''-[benzene-1,2,3-triyltri(oxy)]tris[N,N-diethylethylamine]

Suppliers94 total

国药集团化学试剂有限公司86-21-63210123 · [email protected]
北京华美互利生物化工010-56205725 · [email protected]
阿诺西(上海)生物技术有限公司400-1107768 15058188853 · [email protected]
上海阿拉丁生化科技股份有限公司400-6206333 13167063860 · [email protected]
湖南韵邦生物科技股份有限公司0731-88532326 13319508186 · [email protected]
Hebei Chuanghai Biotechnology Co., Ltd+86-17732866630 · [email protected]
上海康朗生物科技有限公司021-61998208 18217752821 · [email protected]
成都超九八生物科技有限公司13348960310 13348960310 · [email protected]
艾吉析科技(上海)有限公司17717235263 · [email protected]
上海如吉生物科技发展有限公司+86-21-65211385-8001 36031160 · [email protected]
Dayang Chem (Hangzhou) Co.,Ltd.+86-0571-88938639 17705817739 · [email protected]
Hebei Yanxi Chemical Co., Ltd.+86-17531190177 · [email protected]
浙江珲达生物科技有限公司0571-89903022 18679456698 · [email protected]
上海弘顺生物科技有限公司15901914505 · [email protected]
上海颖心实验室设备有限公司021-59178156 17002132182 · [email protected]
广东元丰化学试剂有限公司0751-2829979 13318593351 · [email protected]
广东云星生物技术有限公司0751-18902340975/189023400307 18902340307 · [email protected]
MedBio脉铂医药021-69568360 18916172912 · [email protected]
怀化市冰峰化工有限公司0745-2866851 17711757908 · [email protected]
Nanjing Duly Biotech Co.,Ltd+86-18013301590 · [email protected]
医恩医疗系统研发(上海)有限公司021-58958002 18930822973 · [email protected]
广东谦进化学试剂有限公司0751-2818792 13435114148 · [email protected]
BOC Sciences1-631-485-4226; 16314854226 · [email protected]
湖北扬信医药科技有限公司0714-3999001 19171453112 · [email protected]
ChemeGen 中国18818260767 · [email protected]
四川库利南科技有限公司400-1166-196 18981987031 · [email protected]
斯百全化学(上海)有限公司021-021-021-67601398-809-809-809 15221380277 · [email protected]
上海思域化工科技有限公司86-21-34053660 · [email protected]
AdooQ BioScience, LLC+1 (866) 930-6790 · [email protected]
江苏艾康生物医药研发有限公司025-66113011 13913916777 · [email protected]
TOKYO CHEMICAL INDUSTRY CO., LTD.03-36680489 · [email protected]
TCI Europe320-37350700 · [email protected]
南京杜莱生物技术有限公司025-84699383-8003;025-846993838003-8003 18013301590 · [email protected]
南京世洲生物科技有限公司13675144456 · [email protected]
上海将来实业股份有限公司400-0066400 13621662912 · [email protected]
上海毕得医药科技股份有限公司400-164-7117 18317119277 · [email protected]
天津普西唐生物医药科技有限公司010-60605840 · [email protected]
陕西缔都医药化工有限公司+86-29-87569262 +86-15003564040 · [email protected]
南京百鑫德诺生物科技有限公司025-58849295 · [email protected]
Chongqing jooe co., ltd+86-15223382610 · [email protected]
凯试(上海)科技有限公司021-50135380 · [email protected]
上海谱科生物技术有限公司021-64705760 18027310741 · [email protected]
Sigma-Aldrich西格玛奥德里奇(上海)贸易有限公司021-61415566 800-8193336 · [email protected]
TargetMol中国(陶术生物)021-021-33632979 15002134094 · [email protected]
上海陶术生物科技股份有限公司+1-781-999-5354; +1-00000000000 · [email protected]
北京诺其雅盛生物科技有限公司4000-819-385 010-62329685 13718666987
上海谱振生物科技有限公司4001650900 13817534909 · [email protected]
广东翁江化学试剂有限公司0751-2815987 13927875076 · [email protected]
HANGZHOU LEAP CHEM CO., LTD.+86-571-87711850 +86-15355479329 · [email protected]
艾吉析科技(上海)有限公司17717235263 17717235263 · [email protected]